Lysiane Molina

发表

Lymphoma Obinutuzumab plus Lenalidomide ( GALEN ) for the treatment of relapse / refractory aggressive lymphoma : a phase II LYSA study

R. Houot, P. Feugier, H. Tilly, 2018 .

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)

P. Feugier, Anne Quinquenel, F. Baran-Marszak, 2021 .